ID
21514
Description
HD16 NCT Nr.: NCT00736320 HD16 for Early Stages - Treatment Optimization Trial in the First-line Treatment of Early Stage Hodgkin Lymphoma; Treatment Stratification by Means of FDG-PET. This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of Progression free survival (PFS). HD17 NCT Nr.: NCT01356680 HD17 for Intermediate Stages - Treatment Optimization Trial in the First-Line Treatment of Intermediate Stage Hodgkin Lymphoma.This study is designed to test the non-inferiority of the experimental arm compared to the standard arm in terms of progression free survival (PFS). HD18 NCT Nr.: NCT00515554 HD18 for Advanced Stages in Hodgkins Lymphoma. This study is designed to test: in patients with negative positron-emission tomography (PET) after 2 cycles of BEACOPPesc chemotherapy: whether the number of cycles can be reduced without compromising progression free survival (PFS) (2 further cycles vs. 6 further cycles) for patients with positive PET after 2 cycles: whether intensifying BEACOPPesc chemotherapy by adding Rituximab improves PFS. Permission granted by: Andreas Engert, M.D. Chairman, German Hodgkin Study Group Professor for Internal Medicine Hematology & Oncology University Hospital of Cologne Department of Internal Medicine I Kerpener Str. 62 D-50924 Köln Phone: +49-221-478-5933/5966 Fax: +49-221-478-3778 a.engert@uni-koeln.de
Keywords
Versions (5)
- 4/24/17 4/24/17 -
- 4/25/17 4/25/17 -
- 5/3/17 5/3/17 -
- 11/14/18 11/14/18 - Sarah Riepenhausen
- 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Uploaded on
April 25, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
German Hodgkin Study Group Study HD16/HD17/HD18 Treatment discontinuation form G6AB
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
Description
Therapieabbruchbogen
Description
Date of discontinuation
Data type
date
Alias
- UMLS CUI [1,1]
- C0457454
- UMLS CUI [1,2]
- C0011008
Description
Reason for discontinuation
Data type
integer
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C0457454
Description
Treatment status
Data type
integer
Alias
- UMLS CUI [1]
- C0749659
Description
Further documentation
Data type
text
Alias
- UMLS CUI [1]
- C0175636
Description
Date of completion
Data type
date
Alias
- UMLS CUI [1]
- C0011008
Description
Signature
Data type
text
Alias
- UMLS CUI [1]
- C1519316
Similar models
Deutsche Hodgkin Studiengruppe: G6AB Therapieabbruchbogen
- StudyEvent: ODM
C1515258 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,2])